# 64Cu-SAR-bisPSMA Positron Emission Tomography of Patients With Known or Suspected Prostate Cancer

> **NCT05286840** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Luke Nordquist, MD** · enrollment: 150 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** 64Cu-SAR-bisPSMA

## Key facts

- **NCT ID:** NCT05286840
- **Lead sponsor:** Luke Nordquist, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-28
- **Primary completion:** 2023-03-28
- **Final completion:** 2023-09-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05286840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05286840, "64Cu-SAR-bisPSMA Positron Emission Tomography of Patients With Known or Suspected Prostate Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05286840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*